The effect of motivational interviewing on smoking cessation intention in patients with lung cancer: A randomized controlled trial.

IF 2.4 4区医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Tobacco Induced Diseases Pub Date : 2026-08-01 eCollection Date: 2026-01-01 DOI:10.18332/tid/219211

Sibel Dogru, Sema Aytaç, Özlem Ovayolu

{"title":"The effect of motivational interviewing on smoking cessation intention in patients with lung cancer: A randomized controlled trial.","authors":"Sibel Dogru, Sema Aytaç, Özlem Ovayolu","doi":"10.18332/tid/219211","DOIUrl":null,"url":null,"abstract":"Introduction: This randomized controlled trial investigated the effect of motivational interviewing (MI) on smoking cessation intention in patients diagnosed with lung cancer.Methods: Patients with lung cancer enrolled in the study were divided into intervention (n=21) and control (n=21) groups based on random sampling after power analysis. Patients in the intervention group received two MI sessions through real-time WhatsApp® video calling, administered by the researcher on day 1 of the study and 15 days later. The control group received standard care. At baseline, both groups completed a baseline questionnaire, the Smoking Cessation Intention Scale (SCIS), the Fagerström test for nicotine dependence (FTND), and the Eastern Cooperative Oncology Group (ECOG) performance status scale. At the end of the study, all scales except the baseline questionnaire were re-administered to both groups.Results: Post-intervention, the control group exhibited significantly lower SCIS scores than the intervention group (17.19 ± 4.7 vs 23.23 ± 4.5, p<0.001). The control group also demonstrated a significant decline in SCIS scores from pre- to post-test (22.90 ± 5.3 vs 17.19 ± 4.7, p<0.001). In the intervention group, mean FTND scores decreased substantially following MI (6.2 ± 2.5 vs 2.5 ± 2.0, p=0.012), whereas the control group showed a small, non-significant reduction in FTND scores (5.6 ± 3.1 vs 4.9 ± 3.2, p=0.178). ECOG performance scores remained stable in both groups across the study period.Conclusions: The findings indicate that two sessions of MI delivered via real-time WhatsApp® video calling did not improve smoking cessation intention in patients with lung cancer. However, it reduced nicotine dependence levels. These findings support the development of personalized cessation programs to bolster quit intentions in this high-risk population.CLINICAL TRIAL REGISTRATION: The study is registered on the official website of ClinicalTrials.govIDENTIFIER: NCT06912113.","PeriodicalId":23202,"journal":{"name":"Tobacco Induced Diseases","volume":"24 ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13450127/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tobacco Induced Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18332/tid/219211","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: This randomized controlled trial investigated the effect of motivational interviewing (MI) on smoking cessation intention in patients diagnosed with lung cancer.

Methods: Patients with lung cancer enrolled in the study were divided into intervention (n=21) and control (n=21) groups based on random sampling after power analysis. Patients in the intervention group received two MI sessions through real-time WhatsApp^® video calling, administered by the researcher on day 1 of the study and 15 days later. The control group received standard care. At baseline, both groups completed a baseline questionnaire, the Smoking Cessation Intention Scale (SCIS), the Fagerström test for nicotine dependence (FTND), and the Eastern Cooperative Oncology Group (ECOG) performance status scale. At the end of the study, all scales except the baseline questionnaire were re-administered to both groups.

Results: Post-intervention, the control group exhibited significantly lower SCIS scores than the intervention group (17.19 ± 4.7 vs 23.23 ± 4.5, p<0.001). The control group also demonstrated a significant decline in SCIS scores from pre- to post-test (22.90 ± 5.3 vs 17.19 ± 4.7, p<0.001). In the intervention group, mean FTND scores decreased substantially following MI (6.2 ± 2.5 vs 2.5 ± 2.0, p=0.012), whereas the control group showed a small, non-significant reduction in FTND scores (5.6 ± 3.1 vs 4.9 ± 3.2, p=0.178). ECOG performance scores remained stable in both groups across the study period.

Conclusions: The findings indicate that two sessions of MI delivered via real-time WhatsApp^® video calling did not improve smoking cessation intention in patients with lung cancer. However, it reduced nicotine dependence levels. These findings support the development of personalized cessation programs to bolster quit intentions in this high-risk population.CLINICAL TRIAL REGISTRATION: The study is registered on the official website of ClinicalTrials.govIDENTIFIER: NCT06912113.

查看原文本刊更多论文

动机访谈对肺癌患者戒烟意向的影响：一项随机对照试验。

简介：本随机对照试验探讨动机访谈（MI）对肺癌患者戒烟意愿的影响。方法：经功率分析，采用随机抽样的方法将纳入研究的肺癌患者分为干预组（n=21）和对照组（n=21）。干预组的患者通过实时WhatsApp®视频通话接受两次MI会话，由研究人员在研究的第一天和15天后进行管理。对照组接受标准治疗。在基线时，两组都完成了基线问卷、戒烟意向量表（SCIS）、Fagerström尼古丁依赖测试（FTND）和东部肿瘤合作组（ECOG）表现状态量表。在研究结束时，除了基线问卷外，所有的量表都被重新给予两组。结果：干预后，对照组的SCIS评分明显低于干预组（17.19±4.7 vs 23.23±4.5）。结论：研究结果表明，通过实时WhatsApp®视频通话进行的两次MI并没有改善肺癌患者的戒烟意愿。然而，它降低了对尼古丁的依赖程度。这些发现支持个性化戒烟计划的发展，以加强这一高危人群的戒烟意愿。临床试验注册：本研究在clinicaltrials . goidentifier: NCT06912113官方网站注册。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Tobacco Induced Diseases SUBSTANCE ABUSE-PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

CiteScore

5.30

自引率

5.40%

发文量

审稿时长

12 weeks

期刊介绍： Tobacco Induced Diseases encompasses all aspects of research related to the prevention and control of tobacco use at a global level. Preventing diseases attributable to tobacco is only one aspect of the journal, whose overall scope is to provide a forum for the publication of research articles that can contribute to reducing the burden of tobacco induced diseases globally. To address this epidemic we believe that there must be an avenue for the publication of research/policy activities on tobacco control initiatives that may be very important at a regional and national level. This approach provides a very important "hands on" service to the tobacco control community at a global scale - as common problems have common solutions. Hence, we see ourselves as "connectors" within this global community. The journal hence encourages the submission of articles from all medical, biological and psychosocial disciplines, ranging from medical and dental clinicians, through health professionals to basic biomedical and clinical scientists.